Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 534

1.

Comparison of Clinical Trials and Administrative Claims to Identify Stroke Among Patients Undergoing Aortic Valve Replacement: Findings From the EXTEND Study.

Strom JB, Zhao Y, Faridi KF, Tamez H, Butala NM, Valsdottir LR, Curtis J, Brennan JM, Shen C, Boulware M, Popma JJ, Yeh RW.

Circ Cardiovasc Interv. 2019 Nov;12(11):e008231. doi: 10.1161/CIRCINTERVENTIONS.119.008231. Epub 2019 Nov 7.

PMID:
31694411
2.

Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.

Russo JJ, Prasad M, Doshi D, Karmpaliotis D, Parikh MA, Ali ZA, Popma JJ, Pershad A, Ohman EM, Douglas PS, O'Neill WW, Leon MB, Moses JW, Kirtane AJ.

Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557. [Epub ahead of print]

PMID:
31693292
3.

Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality.

Lindman BR, Goel K, Bermejo J, Beckman J, O'Leary J, Barker CM, Kaiser C, Cavalcante JL, Elmariah S, Huang J, Hickey GL, Adams DH, Popma JJ, Reardon MJ.

J Am Heart Assoc. 2019 Nov 5;8(21):e014020. doi: 10.1161/JAHA.119.014020. Epub 2019 Oct 31.

4.

Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.

Dauerman HL, Deeb GM, O'Hair DP, Waksman R, Yakubov SJ, Kleiman NS, Chetcuti SJ, Hermiller JB Jr, Bajwa T, Khabbaz K, de Marchena E, Salerno T, Dries-Devlin JL, Li S, Popma JJ, Reardon MJ.

Circ Cardiovasc Interv. 2019 Oct;12(10):e008155. doi: 10.1161/CIRCINTERVENTIONS.119.008155. Epub 2019 Oct 14.

PMID:
31607151
5.

The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.

Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS.

JACC Cardiovasc Interv. 2019 Oct 14;12(19):1985-1987. doi: 10.1016/j.jcin.2019.07.050. No abstract available.

PMID:
31601396
6.

Clinical Outcomes Prior to and Following Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial.

Kereiakes DJ, Ellis SG, Metzger DC, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, Tan SH, Ediebah DE, Simonton C, Stone GW; ABSORB III Investigators.

Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.042584. [Epub ahead of print]

PMID:
31553222
7.

Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.

Kundi H, Faridi KF, Wang Y, Wadhera RK, Valsdottir LR, Popma JJ, Kramer DB, Yeh RW.

Circulation. 2019 Sep 10;140(11):969-971. doi: 10.1161/CIRCULATIONAHA.119.040788. Epub 2019 Sep 9. No abstract available.

PMID:
31498696
8.

Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.

Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T; SURTAVI Trial Investigators.

Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.118.039564. [Epub ahead of print]

PMID:
31476897
9.

The Impact of Basal Septal Hypertrophy on Outcomes after Transcatheter Aortic Valve Replacement.

Kiefer NJ, Salber GC, Burke GM, Chang JD, Guibone KA, Popma JJ, Hahn RT, Pinto DS, Strom JB.

J Am Soc Echocardiogr. 2019 Nov;32(11):1416-1425. doi: 10.1016/j.echo.2019.06.012. Epub 2019 Aug 26.

PMID:
31466847
10.

Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial.

Kandzari DE, Karmpaliotis D, Kini AS, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Zhao W, McGreevy R.

Catheter Cardiovasc Interv. 2019 Oct 1;94(4):509-515. doi: 10.1002/ccd.28436. Epub 2019 Aug 24.

PMID:
31444897
11.

Transcatheter Aortic-Valve Replacement in Low-Risk Patients. Reply.

Popma JJ, Reardon MJ.

N Engl J Med. 2019 Aug 15;381(7):685. doi: 10.1056/NEJMc1908500. No abstract available.

PMID:
31412190
12.

Comparison of Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Implantation With 31-mm CoreValve Versus 34-mm Evolut R Bioprostheses from the STS/ACC TVT Registry.

Tang GHL, Reardon MJ, Kodali SK, Hermiller JB Jr, Sorajja P, Szeto WY, Zhang A, Popma JJ.

Am J Cardiol. 2019 Oct 1;124(7):1091-1098. doi: 10.1016/j.amjcard.2019.07.010. Epub 2019 Jul 16.

PMID:
31362879
13.

Self-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry).

Anwaruddin S, Desai ND, Szeto WY, Hermiller JB Jr, Sorajja P, Kodali S, Popma JJ, Giri J, Herrmann HC, Tang GHL, Rame JE, McCarthy FH, Zhang AQ, Reardon MJ.

Am J Cardiol. 2019 Sep 1;124(5):781-788. doi: 10.1016/j.amjcard.2019.05.045. Epub 2019 Jun 6.

PMID:
31311661
14.

Trends in isolated aortic valve replacement in the United States in the early phase of expansion of TAVR.

Kundi H, Cohen DJ, Strom JB, Valsdottir L, Shen C, Choi E, Popma JJ, Yeh RW.

Int J Cardiol. 2019 Oct 1;292:68-72. doi: 10.1016/j.ijcard.2019.06.061. Epub 2019 Jun 22.

PMID:
31255451
15.

Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.

Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ.

JAMA Cardiol. 2019 Jun 19. doi: 10.1001/jamacardio.2019.1856. [Epub ahead of print]

PMID:
31215985
16.

A Practical Two-Stage Frailty Assessment for Older Adults Undergoing Aortic Valve Replacement.

Hosler QP, Maltagliati AJ, Shi SM, Afilalo J, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Kim DH.

J Am Geriatr Soc. 2019 Oct;67(10):2031-2037. doi: 10.1111/jgs.16036. Epub 2019 Jun 18.

PMID:
31211413
17.

IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population.

Chen Z, Guo W, Jiang W, Wang F, Fu W, Zou Y, Deckers S, Li P, Popma JJ, Jaff MR.

J Endovasc Ther. 2019 Aug;26(4):471-478. doi: 10.1177/1526602819852084. Epub 2019 Jun 17.

18.

iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study.

Laird JR, Loja M, Zeller T, Niazi KAK, Foster MT, Ansel G, Stone DH, Dave RM, Popma JJ, Jaff MR, Massaro JM.

J Vasc Interv Radiol. 2019 Jun;30(6):822-829.e4. doi: 10.1016/j.jvir.2018.12.707. Epub 2019 Apr 25.

19.

Habitual Physical Activity in Older Adults Undergoing TAVR: Insights From the FRAILTY-AVR Study.

Sathananthan J, Lauck S, Piazza N, Martucci G, Kim DH, Popma JJ, Asgar AW, Perrault LP, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Généreux P, Webb JG, Afilalo J.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):781-789. doi: 10.1016/j.jcin.2019.02.049.

PMID:
31000014
20.

Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort.

Kundi H, Popma JJ, Reynolds MR, Strom JB, Pinto DS, Valsdottir LR, Shen C, Choi E, Yeh RW.

Eur Heart J. 2019 Jul 14;40(27):2231-2239. doi: 10.1093/eurheartj/ehz187.

PMID:
30977798
21.

Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.

Strom JB, Tamez H, Zhao Y, Valsdottir LR, Curtis J, Brennan JM, Shen C, Popma JJ, Mauri L, Yeh RW.

Am Heart J. 2019 Jun;212:64-71. doi: 10.1016/j.ahj.2019.02.007. Epub 2019 Mar 6.

PMID:
30953936
22.

Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.

Head SJ, Reardon MJ, Deeb GM, Van Mieghem NM, Popma JJ, Gleason TG, Williams MR, Radhakrishnan S, Fremes S, Oh JK, Chang Y, Boulware MJ, Kappetein AP.

Circ Cardiovasc Interv. 2019 Apr;12(4):e007396. doi: 10.1161/CIRCINTERVENTIONS.118.007396.

PMID:
30929507
23.

Initial Feasibility Study of a New Transcatheter Mitral Prosthesis: The First 100 Patients.

Sorajja P, Moat N, Badhwar V, Walters D, Paone G, Bethea B, Bae R, Dahle G, Mumtaz M, Grayburn P, Kapadia S, Babaliaros V, Guerrero M, Satler L, Thourani V, Bedogni F, Rizik D, Denti P, Dumonteil N, Modine T, Sinhal A, Chuang ML, Popma JJ, Blanke P, Leipsic J, Muller D.

J Am Coll Cardiol. 2019 Mar 26;73(11):1250-1260. doi: 10.1016/j.jacc.2018.12.066.

PMID:
30898200
24.

Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.

Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators.

N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.

PMID:
30883053
25.

Delirium Incidence and Functional Outcomes After Transcatheter and Surgical Aortic Valve Replacement.

Shi SM, Sung M, Afilalo J, Lipsitz LA, Kim CA, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Lee J, Marcantonio ER, Kim DH.

J Am Geriatr Soc. 2019 Jul;67(7):1393-1401. doi: 10.1111/jgs.15867. Epub 2019 Mar 18.

PMID:
30882905
26.

Sex-Specific Determinants of Outcomes After Transcatheter Aortic Valve Replacement.

Pighi M, Piazza N, Martucci G, Lachapelle K, Perrault LP, Asgar AW, Lauck S, Webb JG, Popma JJ, Kim DH, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Noiseux N, Trnkus A, Afilalo J.

Circ Cardiovasc Qual Outcomes. 2019 Mar;12(3):e005363. doi: 10.1161/CIRCOUTCOMES.118.005363.

PMID:
30879326
27.

Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement.

Kim DH, Afilalo J, Shi SM, Popma JJ, Khabbaz KR, Laham RJ, Grodstein F, Guibone K, Lux E, Lipsitz LA.

JAMA Intern Med. 2019 Mar 1;179(3):383-391. doi: 10.1001/jamainternmed.2018.6738.

PMID:
30715097
28.

Causes of death in intermediate-risk patients: The Randomized Surgical Replacement and Transcatheter Aortic Valve Implantation Trial.

Amrane H, Deeb GM, Popma JJ, Yakubov SJ, Gleason TG, Van Mieghem NM, Reardon MJ; SURTAVI Trial Causes of Death Working Group.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):718-728.e3. doi: 10.1016/j.jtcvs.2018.11.129. Epub 2018 Dec 13.

PMID:
30709668
29.

Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.

Sharma SK, Bolduan RW, Patel MR, Martinsen BJ, Azemi T, Giugliano G, Resar JR, Mehran R, Cohen DJ, Popma JJ, Waksman R.

Catheter Cardiovasc Interv. 2019 Aug 1;94(2):187-194. doi: 10.1002/ccd.28099. Epub 2019 Jan 25.

PMID:
30681262
30.

Hospital Variation in the Utilization of Short-Term Nondurable Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock.

Strom JB, Zhao Y, Shen C, Chung M, Pinto DS, Popma JJ, Cohen DJ, Yeh RW.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007270. doi: 10.1161/CIRCINTERVENTIONS.118.007270.

PMID:
30608880
31.

Comparison of Local Versus General Anesthesia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry).

Attizzani GF, Patel SM, Dangas GD, Szeto WY, Sorajja P, Reardon MJ, Popma JJ, Kodali S, Chenoweth S, Costa MA.

Am J Cardiol. 2019 Feb 1;123(3):419-425. doi: 10.1016/j.amjcard.2018.10.041. Epub 2018 Nov 6.

PMID:
30527797
32.

The Value of Claims-Based Nontraditional Risk Factors in Predicting Long-term Mortality After MitraClip Procedure.

Kundi H, Popma JJ, Valsdottir LR, Shen C, Faridi KF, Pinto DS, Yeh RW.

Can J Cardiol. 2018 Dec;34(12):1648-1654. doi: 10.1016/j.cjca.2018.10.002. Epub 2018 Oct 13.

PMID:
30527154
33.

Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement.

Kundi H, Popma JJ, Khabbaz KR, Chu LM, Strom JB, Valsdottir LR, Shen C, Yeh RW.

JAMA Cardiol. 2019 Jan 1;4(1):16-22. doi: 10.1001/jamacardio.2018.4051.

PMID:
30516798
34.

Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.

Chetcuti SJ, Deeb GM, Popma JJ, Yakubov SJ, Grossman PM, Patel HJ, Casale A, Dauerman HL, Resar JR, Boulware MJ, Dries-Devlin JL, Li S, Oh JK, Reardon MJ.

JACC Cardiovasc Imaging. 2019 Jan;12(1):67-80. doi: 10.1016/j.jcmg.2018.07.028. Epub 2018 Nov 15.

PMID:
30448116
35.

Prevalence and Outcomes of Isolated Tricuspid Valve Surgery Among Medicare Beneficiaries.

Kundi H, Popma JJ, Cohen DJ, Liu DC, Laham RJ, Pinto DS, Chu LM, Strom JB, Shen C, Yeh RW.

Am J Cardiol. 2019 Jan 1;123(1):132-138. doi: 10.1016/j.amjcard.2018.09.016. Epub 2018 Sep 27.

PMID:
30442362
36.

Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients.

Durko AP, Reardon MJ, Kleiman NS, Popma JJ, Van Mieghem NM, Gleason TG, Bajwa T, O'Hair D, Brown DL, Ryan WH, Chang Y, De Leon SD, Kappetein AP.

J Am Coll Cardiol. 2018 Oct 30;72(18):2109-2119. doi: 10.1016/j.jacc.2018.07.093.

37.

Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.

Kundi H, Valsdottir LR, Popma JJ, Cohen DJ, Strom JB, Pinto DS, Shen C, Yeh RW.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e005048. doi: 10.1161/CIRCOUTCOMES.118.005048.

38.

Trends in Isolated Surgical Aortic Valve Replacement According to Hospital-Based Transcatheter Aortic Valve Replacement Volumes.

Kundi H, Strom JB, Valsdottir LR, Elmariah S, Popma JJ, Shen C, Yeh RW.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2148-2156. doi: 10.1016/j.jcin.2018.07.002. Epub 2018 Oct 17.

PMID:
30343022
39.

Interaction Between Frailty and Access Site in Older Adults Undergoing Transcatheter Aortic Valve Replacement.

Drudi LM, Ades M, Asgar A, Perrault L, Lauck S, Webb JG, Rassi A, Lamy A, Noiseux N, Peterson MD, Labinaz M, Lefèvre T, Popma JJ, Kim DH, Martucci G, Piazza N, Afilalo J.

JACC Cardiovasc Interv. 2018 Nov 12;11(21):2185-2192. doi: 10.1016/j.jcin.2018.06.037. Epub 2018 Oct 17.

PMID:
30343019
40.

Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.

Pineda AM, Kevin Harrison J, Kleiman NS, Reardon MJ, Conte JV, O'Hair DP, Chetcuti SJ, Huang J, Yakubov SJ, Popma JJ, Beohar N.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):740-748. doi: 10.1002/ccd.27928. Epub 2018 Oct 20.

PMID:
30341970
41.

Primary MR remains undertreated.

Feldman T, Smith R 2nd, Popma JJ.

Cardiovasc Revasc Med. 2018 Dec;19(8):905-906. doi: 10.1016/j.carrev.2018.10.015. Epub 2018 Oct 15. No abstract available.

PMID:
30340954
42.

Safety and efficacy of dedicated guidewire and microcatheter technology for chronic total coronary occlusion revascularization: principal results of the Asahi Intecc Chronic Total Occlusion Study.

Kandzari DE, Grantham JA, Karmpaliotis D, Lombardi W, Moses JW, Nicholson W, Cook S, Pershad A, Popma JJ.

Coron Artery Dis. 2018 Dec;29(8):618-623. doi: 10.1097/MCA.0000000000000668.

PMID:
30308588
43.

5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.

Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, Kleiman NS, Chetcuti S, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte JV, Mumtaz M, Oh JK, Huang J, Adams DH; CoreValve U.S. Pivotal High Risk Trial Clinical Investigators.

J Am Coll Cardiol. 2018 Dec 4;72(22):2687-2696. doi: 10.1016/j.jacc.2018.08.2146. Epub 2018 Sep 21.

PMID:
30249462
44.

Effect of Baseline Aortic Regurgitation on Mortality in Patients Treated With Transcatheter or Surgical Aortic Valve Replacement (from the CoreValve US Pivotal Trial).

Grayburn PA, Oh JK, Reardon MJ, Popma JJ, Deeb GM, Boulware M, Huang J, Stoler RC.

Am J Cardiol. 2018 Nov 1;122(9):1527-1535. doi: 10.1016/j.amjcard.2018.07.018. Epub 2018 Aug 3.

PMID:
30172363
45.

Frailty Phenotype and Deficit Accumulation Frailty Index in Predicting Recovery After Transcatheter and Surgical Aortic Valve Replacement.

Shi S, Afilalo J, Lipsitz LA, Popma JJ, Khabbaz KR, Laham RJ, Guibone K, Grodstein F, Lux E, Kim DH.

J Gerontol A Biol Sci Med Sci. 2018 Aug 25. doi: 10.1093/gerona/gly196. [Epub ahead of print]

46.

Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial.

Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Popma JJ, Gao R, Stone GW.

EuroIntervention. 2018 Aug 3;14(5):e554-e561. doi: 10.4244/EIJ-D-17-00796.

47.

Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.

Goldfarb M, Lauck S, Webb JG, Asgar AW, Perrault LP, Piazza N, Martucci G, Lachapelle K, Noiseux N, Kim DH, Popma JJ, Lefèvre T, Labinaz M, Lamy A, Peterson MD, Arora RC, Morais JA, Morin JF, Rudski LG, Afilalo J.

Circulation. 2018 Nov 13;138(20):2202-2211. doi: 10.1161/CIRCULATIONAHA.118.033887.

PMID:
29976568
48.

Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis.

Rogers T, Waksman R, Harrison JK, Deeb GM, Zhang AQ, Hermiller JB Jr, Popma JJ, Reardon MJ.

Am J Cardiol. 2018 Jun 1;121(11):1358-1364. doi: 10.1016/j.amjcard.2018.02.008. Epub 2018 Mar 1.

PMID:
29680171
49.

Utilization, In-Hospital Mortality, and 30-Day Readmission After Percutaneous Mitral Valve Repair in the United States Shortly After Device Approval.

Faridi KF, Popma JJ, Strom JB, Shen C, Choi E, Yeh RW.

Am J Cardiol. 2018 Jun 1;121(11):1365-1372. doi: 10.1016/j.amjcard.2018.02.016. Epub 2018 Mar 1.

PMID:
29627105
50.

Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial.

Okada K, Honda Y, Kitahara H, Otagiri K, Tanaka S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T; ABSORB Japan Investigators.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):648-661. doi: 10.1016/j.jcin.2017.11.034.

Supplemental Content

Loading ...
Support Center